Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Killing AML: RIPK3 leads the way

Ulrike Höckendorf1, Monica Yabal1, Philipp J Jost1

  • 1a III. Medizinische Klinik für Hämatologie und Internistische Onkologie, Klinikum rechts der Isar, Technische Universität München , Munich , Germany.

Cell Cycle (Georgetown, Tex.)
|October 12, 2016
PubMed
Summary

No abstract available in PubMed .

Keywords:
AMLRIPK3inflammasomeleukemia initiating cellsregulated necrosis

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Murine models of lung cancer as a platform to investigate cell death.

Methods in cell biology·2026
Same author

Cell death in cancer.

Cell·2026
Same author

Aberrant methylation limits antitumoral inflammation in lung adenocarcinoma by restricting RIPK3 expression.

Science advances·2026
Same author

Early Detection of Cell Death Using Transmembrane Water Exchange Magnetic Resonance Imaging.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2025
Same author

Targeting hexokinase 2 to induce breast cancer cell senescence.

British journal of pharmacology·2025
Same author

Lymphotoxin alpha eradicates acute myeloid leukemia and simultaneously promotes healthy hematopoiesis in mice.

Science translational medicine·2025